TABLE 4.

Differences pre‐ and 5 years treatment between‐groups and intra‐groups (means ± SD)

Defect configuration	Ia (n = 9)	Ib (n = 17)	Ic (n = 11)	Id (n = 9)	Ie (n = 5)	p (between)
PUS elimination (%)	3/3 (100)	2/2 (100)Ø	4/4 (100)	4/4 (100)	1/2 (50)	0.219
p (intra)	p = 0.083	p = 1.000	p = 0.046	p = 0.046	p = 0.317
PD (mm)	1.67 ± 0.94	2.41 ± 1.30	3.32 ± 1.82	3.22 ± 1.61	4.60 ± 2.75	0.042
p (intra)	p = 0.012	p < 0.001	p = 0.003	p = 0.008	p = 0.042
PD≥6 mm§	1.67 ± 1.00	1.82 ± 1.33	2.45 ± 1.69	2.56 ± 1.42	3.00 ± 1.22	0.182
p (intra)	p = 0.011	p = 0.001	p = 0.006	p = 0.011	p = 0.041
Deepest PD (mm)	2.89 ± 1.90	3.41 ± 2.00	4.36 ± 2.16	4.67 ± 2.35	5.00 ± 2.35	0.411
p (intra)	p = 0.012	p < 0.001	p = 0.003	p = 0.007	p = 0.042
KT mm)	1.11 ± 0.93	0.35 ± 1.37	0.64 ± 1.29	0.22 ± 1.48	1.00 ± 0.71	0.471
p (intra)	p = 0.014	p = 0.227	p = 0.143	p = 0.726	p = 0.059
BOP (%)	38.9 ± 43.5	57.4 ± 26.2	56.8 ± 46.2	52.8 ± 49.1	60.0 ± 41.8	0.836
p (intra)	p = 0.044	p < 0.001	p = 0.010	p = 0.020	p = 0.063
PI (%)	−5.6 ± 32.5	−1.5 ± 33.6	−4.6 ± 38.4	−5.6 ± 39.1	10.0 ± 22.4	0.219
p (intra)	p = 0.581	p = 0.952	p = 0.914	p = 0.595	p = 0.317

Kruskal‐Wallis test (between‐groups comparisons), Wilcoxon test (intra‐group comparisons).

Abbreviations: Bop, Bleeding on probing at the implant site; Pl, Plaque at the implant site.

^§Number of sites per patient with PD ≥ 6mm.